The uncertainty prevailing over pediatric requirements for medicines in Europe: from new active substance to SPC protection and the MedDRA
This article was originally published in SRA
Executive Summary
In the first of a series of articles by Geneviève Michaux on the notoriously complex EU Paediatric Regulation, the Hunton & Williams lawyer focuses on the uncertainty of the legislation with regard to new medicinal products.